Corvus Pharmaceuticals
CRVS
CRVS
55 hedge funds and large institutions have $288M invested in Corvus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 6 closing their positions.
Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
27
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $8K | 682 | -1,581 | -70% |
|
|
AIP
52
Ameritas Investment Partners
Lincoln,
Nebraska
| $3K | 259 | – | – |
|
|
MAM
53
Meeder Asset Management
Dublin,
Ohio
| $1K | 108 | +10 | +10% |
|
54
Daiwa Securities Group
Tokyo,
Japan
| $1K | 116 | +116 | New |
|
55
Jennison Associates
New York
| – | – | -466,724 | Closed |
|
|
TI
56
Trexquant Investment
Stamford,
Connecticut
| – | – | -17,971 | Closed |
|
57
SG Americas Securities
New York
| – | – | -14,438 | Closed |
|
58
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | – | -14,026 | Closed |
|
59
Russell Investments Group
London,
United Kingdom
| – | – | -1,500 | Closed |
|
60
Parallax Volatility Advisers
San Francisco,
California
| – | – | -1,302 | Closed |
|
61
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 3 | -81 | -96% |
|